[Molecular mechanism of apoptosis inhibition by IAPs and its implication to cancer therapy].
Naito
Mikihiko
M
Institute of Molecular and Cellular Biosciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D017209:Apoptosis / Q000235:genetics* / Q000502:physiology; D020169:Caspases / Q000378:metabolism; D015195:Drug Design; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins / Q000037:antagonists & inhibitors* / Q000502:physiology*; D009369:Neoplasms / Q000188:drug therapy* / Q000209:etiology; D051636:X-Linked Inhibitor of Apoptosis Protein / Q000037:antagonists & inhibitors / Q000502:physiology
D000970:Antineoplastic Agents; C401541:BIRC6 protein, human; D051034:Inhibitor of Apoptosis Proteins; D051636:X-Linked Inhibitor of Apoptosis Protein; D020169:Caspases